Quality and clinical governance
Quality is one of Life Healthcare’s core values and a key
business strategy. Life Healthcare is the only healthcare
organisation in southern Africa to have achieved multisite
ISO 9001:2008 certification. All hospitals have met
the criteria based on ongoing internal audits as well
as surveillance audits conducted by an independent
ISO certification agent. This accreditation confirms Life
Healthcare’s standing as a world class provider of quality
healthcare.
The need to improve the overall healthcare delivery
system in South Africa is well recognised and has called
for a new approach to collaboration among all role
players. With this in mind, Life Healthcare is participating
in an industry quality initiative called Best Care … Always.
This includes strategic and hands-on interaction with
the Department of Health in addressing challenges in
healthcare delivery.
Quality management system
The Life Healthcare quality management system is
sustainable and consistent across all hospitals. It
is based on a factual assessment through ongoing
management and measurement. Hospitals are
assessed on their overall quality management,
leadership responsibilities, and quality aspects in the
nursing, pharmacy, patient services and engineering
departments. Results are benchmarked across the group
and form part of the performance management of senior
hospital leaders. Stringent criteria promote compliance
with procedures.
We have established a balance between clinical excellence
(health) and patient experience (care). Clinical excellence
(iQ) ensures that patients receive world class clinical care.
This is balanced against the patient experience (Qe) which
addresses the needs of patients and their families including
emotional support, communication, physical facilities,
services rendered by outsourced service providers and
billing accuracy.
 |
| |
|
|
|
|
| › |
Infection control |
|
› |
Patient satisfaction |
| › |
Patient health and safety |
|
› |
Customer loyalty |
| › |
Clinical governance |
|
› |
Staff at the heart of quality |
| › |
International benchmarking |
|
|
|
| › |
Clinical improvement focus areas |
|
|
|
Quality scorecard
The five key aspects that the quality scorecard measures
consistently across all hospitals and consolidates monthly
include:
| › |
patient/customer satisfaction (CSF) |
| › |
quality management system |
| › |
patient health and safety |
| › |
employee health and safety, and |
| › |
clinical outcomes improvements benchmarked against
international best practice. |
The scorecard reflecting the Group average (shown
below) focuses attention and effort on continual
improvement in a manner that is measurable and
quantifiable.
| |
Measure |
FY2010 |
|
FY2009 |
|
Target |
|
| |
|
|
FY2010 |
|
| |
Patient/customer relations |
|
|
|
|
|
|
| |
Net promoter score |
94.6% |
|
93.9% |
|
All hospitals over 90% |
|
| |
CSF score |
98.04% |
|
97.83% |
|
|
|
| |
Health and safety measures |
|
|
|
|
|
|
| |
Patient incident rate |
4.27 per 1 000 PPDs |
|
4.27 per 1 000 PPDs |
|
5.5 per 1 000 PPDs |
|
| |
|
7.25 per 200 000 |
|
7.99 per 200 000 |
|
8.4 per 200 000 |
|
| |
Employee incident rate |
labour hours |
|
labour hours |
|
labour hours |
|
| |
|
|
|
|
|
* Total incidents = patient, |
|
| |
Total incident rate |
|
|
|
|
property and environment |
|
| |
(excluding employee incidents) |
5.82 per 1 000 PPDs |
|
5.32 per 1 000 PPDs |
|
and external stakeholders |
|
| |
Clinical outcomes |
|
|
|
|
|
|
| |
Infection prevention rates – outcomes measures |
|
|
|
|
|
|
| |
HAIs (healthcare associated infections) |
1.06 |
|
1.30 |
|
– |
|
| |
VAP (ventilator associated pneumonia) |
8.81 |
|
11.51 |
|
10.0 per 1 000 VAP days |
|
| |
|
|
|
|
|
1.2 per 1 000 |
|
| |
SSI (surgical site infection) |
1.26 |
|
2.05 |
|
theatre cases |
|
| |
|
|
|
|
|
Canadian goal |
|
| |
|
|
|
|
|
from average of |
|
| |
CLABSI (central line associated |
|
|
|
|
5 to < 1.9 CR-BSI |
|
| |
bloodstream infection) |
2.55 |
|
3.73 |
|
per 1 000 CL days |
|
| |
CAUTI (catheter associated |
|
|
|
|
|
|
| |
urinary tract infection) |
2.25 |
|
2.57 |
|
– |
|
Clinical excellence (iQ)
Life Healthcare’s clinical excellence focuses on the
following areas:
| › |
Ensuring that clinical care is provided by appropriately
qualified and registered practitioners. |
| › |
Continuously monitoring and evaluating patients’
clinical care. |
| › |
Conducting regular internal and external clinical care
audits. |
| › |
Implementing evidence based clinical quality practised
to improve patient outcome. |
| › |
Systematically collecting and analysing group wide
data on patient visits, hospital stays and outcomes to
determine changes and trends. |
Clinical outcomes improvement
Working with our doctors, we have identified proven
interventions and we measure our compliance to
international evidence based practices of the Institute
for Healthcare Improvement 100K Lives campaign,
Canadian Safer Healthcare Now work, the American
Alliance for Cardiac Care Excellence and the World
Health Organisation World Alliance for Patient Safety.
Prevention of healthcare associated infections (HAIs)
According to the WHO patient safety initiative, healthcare
associated infections (HAIs) remain the most frequent,
costly and life threatening adverse event in healthcare
facilities. Life Healthcare’s infection prevention and risk
management department is involved in all aspects of
the business including nursing, education, procurement,
hospital services, operating theatres, sterile services,
clinical and general engineering, renovations and new
construction as well as occupational health.
In the USA recent estimates suggest there are
approximately 4.5 infections per 100 admissions. In
reducing the incidence of HAIs, Life Healthcare has
had excellent results in the following fields after having
adopted a ‘bundled’ approach (see graphs for results):
| › |
Ventilator associated pneumonia (VAP) |
| › |
Central line associated bloodstream infection (CLABSI) |
| › |
Surgical site infection (SSI) |
| › |
Catheter-associated urinary tract infection (CAUTI) |
A ‘bundle’ is an evidence based, well researched
intervention implemented together for all patients, and
has been proved to reduce infections.
Cardiac excellence project
Life Healthcare embarked on the process of identifying
proven interventions which reduce morbidity and
mortality in patients with acute myocardial infarction
(AMI). Together with our supporting doctors, we started
measuring our compliance to these evidence based
practices. As with our infection related clinical outcomes
improvement campaigns, our cardiac excellence
initiative has as its foundation the work done by the
Institute of Healthcare Improvement (IHI), Canadian
Safer Healthcare Now AMI campaigns and the American
Alliance for Cardiac Care Excellence (ACE). These are
based on leading healthcare organisations partnering
with international cardiologists to ensure that every
hospitalised patient suffering from acute myocardial
infarction receives the right care, at the right time, every
time. We acknowledge the significant support and
contribution of these organisations.
The following components of care form part of our
cardiac excellence project:
| › |
Early administration of aspirin on arrival. |
| › |
Timely initiation of re-perfusion (restoring blood flow
to the cardiac muscle by thrombolytic therapy and/or
coronary intervention). |
| › |
Administration of ACE inhibitors or angiotensin receptor
blockers (ARBs) to improve cardiac function. |
| › |
Administration of beta-blockers to improve cardiac
function. |
| › |
Prescription of aspirin at discharge to prevent further
blood clot formation. |
| › |
Prescription of statins at discharge to reduce high
cholesterol levels. |
| › |
Education on cessation of smoking at discharge. |
Life Healthcare has implemented these specified
components of care at our hospitals with dedicated
cardiac units. We are measuring compliance on an
ongoing basis. Results have been heartening, showing
reduced mortality rates for our patients.
Qe – Patient experience
Patient satisfaction
To obtain accurate and reliable feedback on patients’
perceptions of the quality of our hospital care, Life
Healthcare measures patient satisfaction through a
Q-evaluator, an interactive electronic patient monitoring
and feedback system adopted from international
customer loyalty measurement trends. This measures
our patients’ perception of a number of service aspects
specific to individual departments and units within our
hospitals, and enables management to gauge service
levels. On average the group receives more than
1.2 million responses per year on this system which
means that each patient averages two opportunities
to provide feedback during hospitalisation. The overall
patient feedback score for 2010 was 98.03%.
This system is supported by a manual comment card
process that patients utilise to provide qualitative
feedback and comments. During the year over
185 000 cards were returned and 94.2% of these cards
contained positive comments. Complaints are treated
as a priority for quick resolution and the opportunity to
ensure our patients’ ultimate satisfaction.
Net promoter score
Life Healthcare uses this as the overall measure
of customer satisfaction. This loyalty measurement
is based on a single question: “How likely is it that
you would recommend this Company to a friend or
colleague?” A customer response indicating a high
likelihood of recommending the Company is indicative
of a patient whose needs and requirements have been met and such a patient is known as a promoter.
A patient who is undecided or unlikely to recommend
Life Healthcare is a detractor, and the score is
calculated by subtracting the detractors from the
promoters.
Patient health and safety measures
All patient incidents are reported and fully
investigated by responsible managers. Remedial
action is implemented to avoid recurrence of similar
incidents in other units. Incidents are recorded on
an electronic reporting system and are categorised
by type, business unit and department in which the
incident occurred. Detailed statistics are recorded and
analysed through the use of a sophisticated electronic
tracking system implemented throughout the group’s
hospitals. This allows for trending, a factual approach
to decision making, and the implementation of
preventive measures.
The overall patient incident rate is measured as a ratio
of the number of incidents per 1 000 paid patient days
(PPDs). Two internationally accepted high risk areas
receive specific and ongoing management attention in
all hospitals. These are medication incidents and slips
and falls.
| |
Measure |
|
|
|
|
|
|
| |
per 1 000 PPDs |
FY2010 |
|
FY2009 |
|
FY2008 |
|
| |
Patient incident rate |
4.27 |
|
4.27 |
|
5.5 |
|
| |
Medication rate |
2.00 |
|
2.02 |
|
2.2 |
|
| |
Slips and falls rate |
0.71 |
|
0.69 |
|
1.2 |
|
Patient incidents
The overall patient incident rate has decreased from
5.5 per 1 000 PPDs in 2008 to 4.27 in 2009. During the
financial year under review the rate remained flat at 4.27.
This unchanged rate is partly due to a continued effort in
the group to encourage 100% reporting of incidents.
Medication incidents
The overall medication incident rate has decreased to
2.00 per 1 000 PPDs from 2.2 in 2008. Life Healthcare
continues to review these incidents and involves nursing
and pharmacy staff, quality specialists and doctors in
training to mitigate this risk.
Managing slips and falls
Globally hospitals report that patient slips and falls are
the most common and serious injuries in hospitals. Our
nurses identify high risk patients during the admission
process and include preventive measures in the care
plans for these patients. This approach has contributed
to the reduction in slips and falls from 1.2 per 1 000 PPDs
in 2008 to 0.71 in 2010.
Safety, health and the environment
Employee health and safety
Employees identify and report potential hazardous
conditions through an alert process which addresses
potential hazards. Trends are monitored to highlight
possible new risks requiring mitigation. Various risk
assessments are completed on all pathogens that may
cause disease and to which staff may be exposed. Risks
are mitigated in various ways, for example by the use
of personal protective equipment or isolation facilities,
various infection control precautionary measures,
vaccines or prophylactic treatment.
Trained incident investigators investigate and report all
occupational health and safety incidents to determine
their root causes. Corrective actions are implemented to
address the cause and prevent the recurrence of similar
incidents. Incident trends are monitored throughout the
Group.
All new employees receive quality induction and training
in safety awareness as well as infection prevention
and control. Some employees also act as safety
representatives and link nurses reporting to occupational
health and safety and infection control committees
each month.
Continued safety awareness training and campaigns
at operational levels have resulted in a reduction of
incidents since 2007. Employees are monitored for
occupational exposures such as radiation and are
screened for tuberculosis (TB) and for latex allergies.
In 2010, measles, H1N1 and seasonal influenza
vaccinations were offered to all frontline healthcare
workers.
Employee health and safety
| |
Measure |
|
|
|
|
|
|
| |
(per 200 000 hours) |
FY2010 |
|
FY2009 |
|
FY2008 |
|
| |
Employee incident rate |
7.25 |
|
7.99 |
|
8.4 |
|
The year on year reduction in employee incidents has
been attained by focusing on specific high risk areas
which include employee slips and falls and needle
stick injuries, as well as on continued safety awareness
campaigns and training.
Clinical engineering
Life Healthcare’s clinical engineers are responsible for
the maintenance of all clinical equipment. Employees
who will operate the equipment are appropriately trained
and their competency assessed to ensure safe handling.
Annual audits ensure adherence to and compliance with
safety standards. The group ascribes to the Engineering
and Construction Risk Institute (ECRI) philosophy, unless
the manufacturer’s recommendations are more stringent.
Our clinical engineers are actively involved in the Clinical
Engineering Association of South Africa (CEASA) and
participate in the SA Federation of Hospital Engineers’
programmes.
Environment
Life Healthcare is classified as a low impact organisation in
environmental terms. However, we acknowledge the impact
of our activities on the environment and bear responsibility
for the environmental, health and safety consequences of
our medical services. Our environmental obligations are
managed through regular safety, health, environment and
quality audits and the reviewing of environmental registers
in the Group’s hospitals.
We endorse the need to manage the consumption of our
natural resources in a sustainable manner, to conserve
energy and water, and we are recycling paper, glass and
plastic – all in an effort to reduce our carbon footprint in
line with best international practices.
Healthcare waste management
The Waste Act was enacted to protect health and the
environment by providing reasonable measures for
the prevention of pollution and ecological degradation.
Facilities that generate medical waste may store this for
short periods of time. Life Healthcare is sensitive to the
potential impact that waste generated through our hospitals’
activities could pose to the environment and to health if not
correctly handled, disposed of or destroyed, particularly
as the healthcare waste industry in South Africa has a
history of illegal dumping and insufficient incinerators.
Waste includes infectious waste, drug waste resulting from
cancer treatments, waste from the usage of X-rays, cleaning
concentrates, diesel fuel or motor oil which represent a
danger to the soil or groundwater, and chemicals such as
those used in anaesthetics.
To mitigate the risks within our control, Life Healthcare
ensures that we minimise toxicity through the correct
handling of waste within our facilities and that our waste
disposal contractors meet legislative requirements in
transporting, disposing of or destroying healthcare waste.
Waste is weighed on collection, and Life Healthcare facilities
keep and reconcile documentation on a monthly basis
to monitor that the waste collected by external service
providers was disposed of or destroyed correctly. Our
healthcare waste transporters have tracking systems so
that any deviation in the planned route is reported. Waste
disposal contractors are audited internally and shortcomings are addressed. In addition, an environmental auditing team
has been contracted to conduct independent audits of
service providers.
All Life Healthcare facilities have recycling initiatives and
training is provided to enable staff to reduce the amount
of waste through correct segregation.

Energy usage
Life Healthcare’s primary source of energy is electricity and we purchase 124 367 994 kWh annually for use in our hospitals and other facilities. We have embarked on an energy conservation programme and have identified various initiatives in this regard. Currently we are measuring and creating a baseline to substantiate actual savings after implementation of the conservation initiatives. These will be reported on in 2011.
As a result of frequent power outages in 2009, Life Healthcare spent R 45 million in acquiring secondary back‑up generators at our hospitals. The cost of diesel for the generators is four to six times higher than Eskom’s electricity, but uninterrupted power supply in the event of any one of our primary generators malfunctioning during a power cut, is an imperative in healthcare delivery. Electricity supply to our hospitals stabilised as Eskom reduced its load shedding programme. In 2010, our diesel consumption for the on-site generation of emergency power was 81 273 litres.
Water usage
Water is obtained from municipal or regional utilities.
Life Healthcare’s total water usage for the year was
1 194 552 kilolitres. At present less than 0.5% or
6 400 kilolitres is recycled or reused, however we
have identified initiatives that will reduce our water
consumption and this will be reported on in 2011.
|